---
title: "Beijing Tide Pharmaceutical: Loxoprofen Sodium Gel Patch approved for market launch, achieving a full pipeline layout in the pain relief field"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/227479045.md"
description: "SINO BIOPHARM's subsidiary Beijing Tide Pharmaceutical announced that its developed Loxoprofen Sodium Gel Patch has recently been approved for marketing by the National Medical Products Administration of China, indicated for inflammation and pain relief for osteoarthritis, muscle pain, and swelling pain caused by trauma"
datetime: "2025-02-07T06:26:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/227479045.md)
  - [en](https://longbridge.com/en/news/227479045.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/227479045.md)
---

# Beijing Tide Pharmaceutical: Loxoprofen Sodium Gel Patch approved for market launch, achieving a full pipeline layout in the pain relief field

SINO BIOPHARM's subsidiary Beijing Tide Pharmaceutical announced that its developed Loxoprofen Sodium Gel Patch has recently been approved for marketing by the National Medical Products Administration of China, indicated for the treatment of osteoarthritis, muscle pain, and inflammation and pain relief caused by trauma

### Related Stocks

- [01177.HK](https://longbridge.com/en/quote/01177.HK.md)

## Related News & Research

- [Sino Biopharm Showcases Promising Obesity Antibody Data and Expands Weight-Loss Pipeline](https://longbridge.com/en/news/286328735.md)
- [Sino Biopharm Advances First-in-Class CCR8 Antibody Into Phase III Gastric Cancer Trial](https://longbridge.com/en/news/285458913.md)
- [17:00 ETLunit Highlights AI-Powered IHC and Tumor Microenvironment Research at ASCO 2026](https://longbridge.com/en/news/287272497.md)
- [03:14 ETDatar Cancer Genetics recibe una histórica aprobación de la FDA estadounidense para CellDx-Tissue](https://longbridge.com/en/news/287174095.md)
- [KOALA trial opens to enrol patients for first‑in‑human KMCAR T‑cell therapy](https://longbridge.com/en/news/287059695.md)